{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5.5","upperLimit":"4180","value":"1310"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"}],"units":"Participants"}],"description":"Mean trough PK plasma concentration over time in the safety population with at least one PK sample collected at timepoints week 5, 9, 13 and 17; only Week 5 data presented.","dispersionType":"Full Range","groups":[{"description":"Oral rucaparib (monotherapy).\n\nRucaparib: Rucaparib will be administered daily.","id":"OG000","title":"Rucaparib"}],"paramType":"MEDIAN","populationDescription":"Safety Population with at least 1 PK sample collected.","reportingStatus":"POSTED","timeFrame":"From enrollment to week 5 of dosing","title":"Trough Plasma PK (Cmin) of Rucaparib Based on Sparse Sampling","type":"SECONDARY","unitOfMeasure":"ng/mL"}